An expert committee of APPCB has pointed out the presence of unapproved products in samples of 15 drug and pharmaceutical manufacturing units. The findings were part of a report sought by the Appellate Authority under the Water (Prevention and Control of Pollution) Act and the Air (Prevention and Control of Pollution) Act, with respect to an appeal filed by 18 drug and pharmaceutical manufacturing units.
The report has mentioned that the products were other than those permitted under Consent For Establishment and Consent For Operation given by the APPCB. A total of 74 illegal products were found and three manufacturing units were found to be producing more than the actual limit under CFE and CFOs. The three units have, however, already applied for new product mixes while a chunk of the “un-consented products” were intermediate products.
About four units were also found to be failing in achieving Zero Liquid Discharge (discharge of pollutants) due to dysfunctional systems. This has interestingly been attributed to untrained staff.
The report, however, did not find anything grossly wrong with these drug units in its conclusion and attributed most of the anomalies to “non-employment of trained staff”.